best-in-class potential – Talk Bio

Actionable Insights Powered by AI

GSK Abandons Phase 2 HPV Vaccine Due to Lack of Best-in-Class Potential

9 months ago talkbio0Tagged best-in-class potential, development aspects, Human Papilloma Virus Vaccine, Phase 2, SmithKline Beecham, Vaccines

GSK, HPV vaccine, phase 2, best-in-class potential, vaccine development